ZMapp against Ebola virus: GMO is action

‪#‎ZMapp‬ is an experimental mixture of three humanized monoclonal antibodies for immunological protection against the ‪#‎Ebola‬ virus, and manufactured in the Nicotiana plant (Here is ‪#‎GMO‬ in Action). On 4 August 2014 the drug was first tested on humans. It was administered to two Americans who had been infected with Ebola. Both people appeared to have had positive results